A compound represented by the formula (I) or pharmacologically acceptable salt thereof exhibits an excellent CRF receptor antagonism.wherein X is a nitrogen atom or CH R1 is -A11-A12 A11 is a single bond or a C1-6 alkylene group A12 is a hydrogen atom a C1-6 alkyl group or a C3-6 cycloalkyl group, etc. R2 is -A21-A22 A21 is a single bond or a C1-6 alkylene group A22 is a hydrogen atom, a C1-6 alkyl group, a C3-6 cycloalkyl group, a non-aromatic heterocyclic group, or a heteroaryl group, etc. R3 is a C1-6 alkyl group, a C3-6 cycloalkyl group, a C1-6 alkoxy group, a C3-6 cycloalkoxy C1-6 alkyl group, di-C1-6 alkyl amino group, a halogen atom, a cyano group, a formyl group, or a carboxyl group, etc R4 is a hydrogen atom or a C1-6 alkoxy group R5 is a halogen atom, a C1-6 alkyl group, or a C1-6 alkoxy group R6 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, a C1-6 alkylthio group, or a C1-6 alkyl sulfinyl group etc. and R7 is a C1-6 alkyl group, a C1-6 alkoxy group, or a C1-6 alkylthio group.
